Validation of Component-Resolved Diagnostics (CRD) for Allergy Testing at Hamad Medical Corporation Immunology Laboratory, Doha, Qatar

World Allergy Organization Journal 2026 Open access

Read full text
Authors: Foziyeh Esmaiel Naji, Raja H.M. Abdelhadi, Abeer Qush, Hana’a Ramadan, Buthaina Shaheen, Yaldez Ibrahim, Asaad Omer Imameldin, Firyal A. Ibrahim, Medhat Z. Askar, Maryam Ali Al‐Nesf, Aziz Alami Chentoufi
DOI: 10.1016/j.waojou.2026.101254
Cited by: 0

Abstract

BACKGROUND/OBJECTIVESComponent-resolved diagnostics (CRD), also known as molecular allergology, measures IgE responses to individual allergenic proteins rather than crude extracts.This approach improves clinical interpretation by (1) predicting reaction severity, (2) distinguishing true sensitization from cross-reactivity, and (3) guiding allergen immunotherapy.

Fields of Study & Subjects

Allergic Rhinitis and Sensitization Food Allergy and Anaphylaxis Research Asthma and respiratory diseases

Publication details

Journal / source
World Allergy Organization Journal
Volume
19
Issue
2
Pages
101254–101254
Publication date
1 February 2026
Language
EN